February 17, 2017
Why the CRISPR patent verdict isn’t the end of the story
news@nature.com - Fetched: February 17th, 2017, 3:00pm UTC
From legal challenges to ongoing experimentation, the story of who owns the rights to CRISPR gene editing is still being written.
Nature News doi: 10.1038/nature.2017.21510